Rare Cancer

Rare cancers, such as Merkel cell carcinoma and retinoblastoma, account for a significant portion of cancer diagnoses worldwide. Due to their rarity, these cancers often have limited clinical data, making diagnosis and treatment challenging. Research into rare cancers focuses on understanding genetic mutations and tumour behaviour to develop targeted therapies. Personalized medicine and immunotherapy have shown promise in treating rare cancers, offering patients new hope. Collaboration between cancer research centres and international registries is essential for pooling data and improving treatment protocols.

 

    Related Conference of Rare Cancer

    November 21-22, 2024

    7th Pathology and Infectious Disease Conference

    Dubai, UAE
    November 28-29, 2024

    20th World Congress on Infection Prevention and Control

    Paris, France
    March 13-14, 2025

    9th International Conference on Rare Diseases

    Prague, Czech Republic
    March 17-18, 2025

    12th International Congress on Infectious Diseases

    Berlin, Germany
    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands

    Rare Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in